Fidelity International’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.1M | Buy |
1,885,000
+70,000
| +4% | +$413K | 0.01% | 529 |
|
2025
Q1 | $10.6M | Buy |
1,815,000
+20,000
| +1% | +$116K | 0.01% | 519 |
|
2024
Q4 | $13.5M | Buy |
1,795,000
+260,000
| +17% | +$1.95M | 0.01% | 502 |
|
2024
Q3 | $12.2M | Buy |
1,535,000
+30,000
| +2% | +$239K | 0.01% | 531 |
|
2024
Q2 | $12.7M | Buy |
1,505,000
+154,365
| +11% | +$1.31M | 0.01% | 494 |
|
2024
Q1 | $11.3M | Buy |
1,350,635
+150,000
| +12% | +$1.26M | 0.01% | 507 |
|
2023
Q4 | $10.1M | Hold |
1,200,635
| – | – | 0.01% | 504 |
|
2023
Q3 | $12M | Hold |
1,200,635
| – | – | 0.01% | 472 |
|
2023
Q2 | $15.4M | Buy |
1,200,635
+13,010
| +1% | +$167K | 0.02% | 441 |
|
2023
Q1 | $11M | Sell |
1,187,625
-38,050
| -3% | -$353K | 0.01% | 476 |
|
2022
Q4 | $13.1M | Buy |
1,225,675
+120,290
| +11% | +$1.29M | 0.02% | 456 |
|
2022
Q3 | $4.47M | Buy |
1,105,385
+15,000
| +1% | +$60.7K | 0.01% | 588 |
|
2022
Q2 | $7.96M | Buy |
1,090,385
+25,010
| +2% | +$183K | 0.01% | 530 |
|
2022
Q1 | $9.59M | Buy |
1,065,375
+40,000
| +4% | +$360K | 0.01% | 539 |
|
2021
Q4 | $11.6M | Buy |
1,025,375
+25,000
| +2% | +$282K | 0.01% | 521 |
|
2021
Q3 | $14.6M | Buy |
1,000,375
+125,030
| +14% | +$1.83M | 0.02% | 484 |
|
2021
Q2 | $14.3M | Buy |
875,345
+50,010
| +6% | +$815K | 0.02% | 502 |
|
2021
Q1 | $16.6M | Sell |
825,335
-200,025
| -20% | -$4.01M | 0.02% | 464 |
|
2020
Q4 | $21.1M | Sell |
1,025,360
-100,010
| -9% | -$2.06M | 0.03% | 400 |
|
2020
Q3 | $19.8M | Buy |
1,125,370
+229,950
| +26% | +$4.04M | 0.02% | 397 |
|
2020
Q2 | $15.2M | Buy |
895,420
+29,995
| +3% | +$508K | 0.02% | 421 |
|
2020
Q1 | $8.33M | Sell |
865,425
-110,200
| -11% | -$1.06M | 0.01% | 476 |
|
2019
Q4 | $11.1M | Buy |
+975,625
| New | +$11.1M | 0.02% | 488 |
|